Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-26 @ 2:11 AM
Study NCT ID:
NCT00300105
Status:
TERMINATED
Last Update Posted:
2008-03-17
First Post:
2006-03-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-10
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2006-12
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-07
First Submit QC Date:
None
Study First Post Date:
2006-03-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-03-14
Last Update Post Date:
2008-03-17
Last Update Post Date Type:
ESTIMATED